• Теги
    • избранные теги
    • Компании736
      • Показать ещё
      Разное235
      • Показать ещё
      Страны / Регионы130
      • Показать ещё
      Международные организации3
      Формат1
      Издания7
      Сферы3
      Люди18
      • Показать ещё
      Показатели5
Thermo Fisher
25 июля, 16:59

Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View

Quest Diagnostics (DGX) continues to ride high on its advanced diagnostic offerings. Also, a raised view buoys optimism.

25 июля, 16:32

Medical Instruments' Jul 26 Earnings Lineup: EW, TMO, VAR

The ongoing political conflict resulting in a delay in policy implementation is a major dampener for Q2 earnings in the Medical space.

25 июля, 15:33

Should You Buy Thermo Fisher Scientific Inc. (TMO) Ahead of Earnings?

Thermo Fisher Scientific Inc. (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

21 июля, 16:28

Will Stryker (SYK) Deliver a Beat this Earnings Season?

The growing adoption of Stryker's (SYK) MAKO robots is expected to drive second-quarter 2017 sales in the orthopedic and reconstructive surgery market.

21 июля, 16:21

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.

21 июля, 16:16

Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock?

Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.

21 июля, 15:54

McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

21 июля, 15:26

IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

21 июля, 01:02

LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards?

With the Covance Drug Diagnostic arm's revenue and margins projected to decline further, LabCorp???s business in Q2 might face disruption.

20 июля, 16:48

Baxter International (BAX) Q2 Earnings: What's in Store?

Despite an upbeat guidance, lower cyclophosphamide sales are likely to mar Baxter International (BAX) performance in the second quarter 2017.

20 июля, 16:47

Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store?

Varian Medical Systems' (VAR) oncology business strength might drive its performance in Q3.

20 июля, 16:39

Align Technology (ALGN) Q2 Earnings: A Beat in the Cards?

Align Technology (ALGN) might ride high in Q2 banking on growth in the Invisalign space.

19 июля, 00:55

What's in Store for athenahealth (ATHN) in Q2 Earnings?

athenahealth Inc. (ATHN) is set to report second-quarter 2017 results on Jul 20.

Выбор редакции
18 июля, 16:51

Will Intuitive Surgical (ISRG) Surprise in Q2 Earnings?

Intuitive Surgical Inc. (ISRG) is scheduled to report second-quarter 2017 results after the closing bell on Jul 20.

18 июля, 16:06

Will Thermo Fisher's (TMO) Q2 Earnings Surpass Expectations?

Strong focus on product launch and emerging market expansion should drive Thermo Fisher (TMO) toward an earnings beat in Q2.

17 июля, 23:15

Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock?

Thermo Fisher Scientific, Inc. (TMO) is on a healthy growth trajectory of late and has rallied 17.7% over the past three months.

17 июля, 15:45

Can Abbott Laboratories (ABT) Pull a Surprise in Q2 Earnings?

Abbott Laboratories (ABT) is scheduled to report second-quarter 2017 results before the opening bell on Jul 20.

10 июля, 17:13

Thermo Fisher at a 52-Week High: What's Driving the Stock?

Share price of Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, MA, scaled a new 52-week high of $177.99 on Jul 7, eventually closing a shade lower at $177.49.

29 июня, 20:50

China 2017 - Perfecting Precision Medicine

http://www.weforum.org/ Precision medicine has the potential to change the way we treat and cure disease. As genomic technologies move from lab to clinic, how can precision medicine be both accessible to and affordable for all? Speakers: - Victor Dzau, President, National Academy of Medicine, USA - Carl-Henrik Heldin, Professor of Molecular Cell Biology, Uppsala University, Sweden - Gianluca Pettiti, President, Greater China, Thermo Fisher Scientific (China), People's Republic of China - Vivian Tan, Vice-President, Strategy and Transformation, Kaiser Permanente, USA - Jeroen Tas, Chief Innovation and Strategy Officer, Royal Philips, Netherlands Moderated by: - Vivienne Parry, Head of Engagement, Genomics England, United Kingdom